Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...

India removes angel tax, a 30% levy on startup investments, aiming to attract foreign capital and support the growing ecosystem. This move is expected to boost innovation and reduce disputes.

The US India Strategic and Partnership Forum (USISPF) praises India's budget for abolishing angel tax, reducing corporate tax rates, and other pro-growth measures.

Nasscom welcomes the government's move to scrap angel tax, reduce TDS for e-commerce operators, and streamline transfer pricing, boosting India's start-up ecosystem and global competitiveness.

India's Commerce Minister Piyush Goyal announces the removal of angel tax for all investors, aimed at attracting capital and promoting startup growth in sectors like deeptech and AI.

India's government estimates its debt to rise to Rs 185 lakh crore in FY25, reaching 56.8 per cent of the GDP. The debt includes external borrowing, public account liabilities, and other liabilities.

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

Ceigall India's Rs 1,253 crore IPO opens on August 1 with a price band of Rs 380-401 per share. The infrastructure company's issue includes fresh issuance and OFS. Learn more.

India's government estimates its debt to rise to Rs 185 lakh crore in FY25, reaching 56.8 per cent of the GDP. The debt includes external borrowing, public account liabilities, and other liabilities.

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

RBI Governor highlights digitalisation's impact on banking, emphasizing next-generation services, affordable finance, and challenges like cybersecurity and data privacy.